Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$IPA Double Down Average down
How’s your 70 looking lmao
Dam down 20 percent already… looks like 8 will be in play here today
That's a great question... I remember trading Moderna a few times. I had it in my watchlist on February 3rd of last year at $20.52, now it's $323 and going to be added into S&P 500. In contrast you can look at Pfizer, hardly any movement at all. IPA has a low float with a price target of 16-22 online. Gonna wait and see what tomorrow may bring in terms of volume. Delta variant is grabbing headlines. Haven't done enough DD on the company yet. All I know is, I wanted in.
Whats your price target here.
Holding overnight, no shares available to short. GLTA
Come on! IPA you can do it!
Holy Mackerel, Andy!!!!!!
yup. we are good. hold. everyone will be able to sell for a positive.
LETS GO!!!!!!!!!!!!!!!!!!!!!
Great company and great CEO. Right place right time. Do some dd. Have been in since the share restructure (I think 1 for 4 or 5, can't remember). Only positives and do some dd. Upton did some research and had an interview. Could be bought out by big pharma. Specialize in cocktails and can cure a lot of things bothering the world lately. Trust me, do the some digging, you will be impressed. Good luck everyone.
I DO, I DO, I DO!!!!!
Indeed!! (By they way, did you steal my circa-proprietary NFT of MYSELF??? HA-HA-HA!!!)
"The OTC confuses the FLUCK out of me. Damn-it!!!"
Who thinks IPA opens above $20 tomorrow?
O.K., THANKS 'M-G'!!! I'm just now flyin' all over the NEWS behind this one (my 9-yr-old helping on HER Apple). WOW, every day we gots yet ANOTHER one of these 'Medical' flyers!!!
I know im holding at least some for tomorrow
Been gone all day, behind DMV & kids! Should I get this TOMORROW, Lord 'M-G'!!!??? I'm scrambling on this Board behind all your DD, etc.!!!
ok genius
Lol no shot
could run to $70 imo
12's might hold, maybe lol
nice call and alert on IPA MonstaGains
Who’s going to be caught holding the bag!! That’s the question.
Break new HOD and its on!
Going again
HUGE!!!!!!!!
YES!!!!! NEW HOD!!!!!!!!!
15 easy imo… off to Golf.
This can be huge!!!!!!!!
SQUEEZE THE SHORTS!
Float 19 milli has been tradet allready
She moves like butter
Looking good so far
This could run like NURO! HUGE NEWS today!
Just got 9,20‘s
Wow! After today imma drink a IPA hahaha
TRANSVAC2 funds a Collaboration between
European and US/Canadian SMEs
on a unique, single-shot SARS-CoV-2 vaccine
LiteVax BV (Oss, the Netherlands), ImmunoPrecise Antibodies (Oss, the Netherlands and Victoria,
Canada) and IRTA (Barcelona, Spain) decided to combine their respective expertise in the field of
immunoadjuvants, antigen design and vaccination evaluation, to develop an effective and safe SARSCoV-2 vaccine for the globe. Feasibility of single-shot approach will be evaluated in large, nonrodent
species by measuring neutralizing antibody responses and immunological memory. Based on results with
similar experimental vaccines, expectations are high. The project is sponsored by TRANSVAC2, a network
of leading European groups working in the field of vaccine R&D and funded by the European Commission
(EC grant agreement N° 730964).
ImmunoPrecise Antibodies exploits it’s PolyTopeTM monoclonal antibody platform for the treatment of
patients against SARS-CoV-2 infection. The platform is of particular interest to identify and optimize
neutralizing epitopes and to design promising antigen candidates. A selection of unique, rationaldesigned subunits will be investigated. LiteVax exploits a novel class of synthetic carbohydrate
derivatives as vaccine adjuvant and preclinical data demonstrate that high responses and strong
immunological memory are obtained already after a first vaccination. As service provider in this
collaboration, IRTA (Barcelona) has all relevant expertise, know-how and facilities to conduct vaccination
studies in large animal species including SARS-CoV-2 vaccines.
With the many COVID19-vaccine initiatives in advanced stage of development, opportunities for new
candidates are controlled activation and modulation of the immune system; high and persistent
immunity, strong memory and no immune-enhanced disease are key. Provided that results are
promising, the project will be a first stepping stone towards clinical development and commercialization
of the concept. Funding by TRANSVAC2/EU acts as a catalyst to crossing boundaries and building an
inspiring collaboration between parties with complementary technologies. By this transatlantic
collaboration we hope to contribute to the idea that global problems should be solved together.
IPATF changed to IPA. Moved to the Nasdaq from the OTC:
https://otce.finra.org/otce/dailyList?viewType=Deletions
Last day trading on the Otc, tomorrow Nasdaq. New all time high coming?
IPATF: effective Nov. 23,2020 a one for 5 reverse split:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
Followers
|
12
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
228
|
Created
|
03/05/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |